A 15 year old State-of-the-art Pharmaceuticals entity from Telangana,India is looking to acquire API manufacturers in India.
Posted By - Investment Banker
Posted date - 07/04/2021
TARGET BRIEF
The company wishes to acquire a running, Profitable API (preferably)manufacturing company with revenues between INR 150-800 Crores
About the Company-
Company is a vertically integrated pharmaceutical company accredited by DCGI,MOH(Turkey),USFDA,BPFK (Malaysia), MOH (UAE). Over the past 15 years, it has expanded its spectrum by establishing state-of-the-art manufacturing facilities in API, Formulations and Clinical Research. The Research Centre is supported by a team of 30 – 35 scientists who brings about 200 person-years of experience
Proposal
Industry
Pharmaceuticals
Sub Industry
API
Deal Size
INR 150 - 800 Cr
Funding Sources
Cash,Fresh Debt,Fresh Equity
Synergies Sought
Manufacturing Strengths (Production/Operations), Access of resource in the industry
Deal Option
Complete Buyout,Minority
Target Location
Pan India
Type
General & Beta Lactum
Product
Any
Export
Yes
Business Operation Information
Business Documents
Recommended Deals
Acquisition opportunity: Agricultural chemicals company is looking to acquire an...
The target should be engaged in API business. Preferable product portfolio incl...
₹ 600 - 700 Cr
A Pharmaceuticals (Contract Research & Manufacturing Services (CRAMS)) entity fr...
The Company is seeking acquisition targets in the CRO and/or CDMO space with the...